Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Invetx
AddedFeb 17, 2024
UpdatedJun 18, 2026
Invetx

Invetx

Series B

Invetx: A leading biopharmaceutical company innovating protein-based therapeutics for improved animal health.

HQ
Boston, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Invetx, founded with the mission to revolutionize animal health through biopharmaceutical innovation, focuses on developing protein-based therapeutics for veterinary use. The company aims to leverage human biotechnology advancements to create a premier platform for animal health solutions. Invetx collaborates with leading biotechnology firms, major investors, and a network of industry experts to develop a portfolio of therapies and technologies that address significant health issues in animals.

Notable figures affiliated with Invetx include Dr. Marcus Remmers, a partner at Novo Holdings and an influential leader in the animal health industry, who serves on the company's Board of Directors. Key achievements include the development of a half-life extension technology platform for canine and feline monoclonal antibody treatments, significantly enhancing their duration of effect. Invetx's impact is underscored by its commitment to addressing chronic conditions like osteoarthritis in pets, aiming to improve the quality of life for animals globally.

Invetx - Similar Companies

Vetigenics logo

Vetigenics

vetigenics.com

Anivive logo

Anivive

anivive.com

Rex Animal Health logo

Rex Animal Health

InterveXion Therapeutics logo

InterveXion Therapeutics

intervexion.com

Animol Discovery logo

Animol Discovery

INVO Fertility logo

INVO Fertility

invobioscience.com

Invitris logo

Invitris

invitris.com

Innoviva logo

Innoviva

inva.com

Invenra logo

Invenra

invenra.com

VetDC logo

VetDC

Agentix logo

Agentix

agentixcorp.com

Animal Biosciences logo

Animal Biosciences

Insigna logo

Insigna

epivara.com

Invea Therapeutics logo

Invea Therapeutics

inveatx.com

iVexSol logo

iVexSol

ivexsol.com

Invetx - Quick Facts

Who are Invetx's competitors?

Companies similar to Invetx include Vetigenics, Anivive, Rex Animal Health and InterveXion Therapeutics.

When was Invetx founded?

Invetx was founded in 2018.

Where is Invetx's headquarters located?

Invetx's headquarters is located in Boston, MA, US.

When was Invetx's last funding round?

Invetx's most recent funding round was for $60.5M (USD) in May 2022.

How much has Invetx raised to-date?

As of May 10, 2022, Invetx has raised a total of $85.8M (USD).

How many employees does Invetx have?

Invetx has 30 employees as of Feb 5, 2024.

Invetx - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
  • Therapeutics
Tags
  • Healthtech
  • Veterinary
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified